Levobunolol (Betagan) is mainly prescribed for which condition?

Levobunolol (Betagan) is primarily prescribed for glaucoma management because it is a non-selective beta-adrenergic antagonist (beta-blocker) that helps lower intraocular pressure in patients with glaucoma or ocular hypertension. By blocking the beta receptors in the eye, Levobunolol reduces the production of aqueous humor, thereby decreasing the pressure inside the eye, which is crucial in preventing damage to the optic nerve associated with glaucoma.

This role in managing intraocular pressure is essential for preserving vision and preventing further complications that can arise from this condition. The other disorders listed, such as diabetic retinopathy, macular degeneration, and cataract prevention, are not directly treated by Levobunolol, as they involve different pathological processes and treatment modalities. Thus, its main indication remains firmly in the realm of glaucoma management.